Carboplatin/Paclitaxel/Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, paclitaxel, and pembrolizumab that can be used in the treatment of breast cancer, cervical cancer, vaginal cancer, vulvar cancer, endometrial carcinoma, head and neck cancers, and metastatic squamous non-small cell lung cancer (NSCLC). Pembrolizumab plus paclitaxel weekly/carboplatin regimen may be used for the treatment of head and neck cancers.

**Synonyms:** - Carboplatin and Paclitaxel (CP) and Pembrolizumab - Carboplatin-Paclitaxel-Pembrolizumab - Carboplatin-Paclitaxel-Pembrolizumab Regimen - Carboplatin/Paclitaxel/Pembrolizumab - Carboplatin/Taxol/Keytruda